| Lowering LDL Cuts Cardio Events in Renal Disease - MedPage Today |
|
|
MedPage Today Explain that the SHARP trial found that patients with chronic kidney disease, both on and off dialysis, had lower LDL cholesterol on the combination of simvastatin and ezetimibe and fewer major ... SHARP published: Ezetimibe/simvastatin reduces risk of atherosclerotic events |